FDA 510(k)

VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance

K-Number: K181766 · 2018-12-10

Decision Date2018-12-10

Product CodeLON

Advisory CommitteeMI

DecisionSubstantially Equivalent

Device Summary

VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance is a medical device manufactured by bioMerieux, Inc.. It received FDA 510(k) clearance on 2018-12-10 under approval number K181766. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance?

VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance is a medical device that received FDA 510(k) clearance on 2018-12-10. It is manufactured by bioMerieux, Inc.. The 510(k) number is K181766.

When was VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance approved by the FDA?

VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance received FDA 510(k) clearance on 2018-12-10, under approval number K181766.

What company makes VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance?

VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance is manufactured by bioMerieux, Inc..

What is the FDA product code for VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance?

The FDA product code for VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance is LON.

Related Clinical Trials

NCT06920407 BreatheWell: Train Your Breathing, Relax Your Body, Open Your Mind ENROLLING_BY_INVITATION NCT06976125 Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting RECRUITING NCT06472245 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor RECRUITING NCT07504926 A Randomised Feasibility Study of CPAP in Large Airway Collapse NOT_YET_RECRUITING

Related PubMed Literature

PMID: 40775863 Use of the Learning Health System to Redesign and Implement a Clinical Decision Support System for Antimicrobial Stewardship. Studies in health technology and informatics (2025)

Other Devices by bioMerieux, Inc.

K162076chromID MRSA K161227VITEK 2 AST-GN Cefepime (<=0.12->=32 ug/mL) K160911VIDAS B.R.A.H.M.S. PCT (PCT) K152075VITEK 2 AST-Gram Negative Ertapenem (<=0.12 - >=8 ug/mL) K151923VITEK 2 AST-Yeast Micafungin (0.06-8 mcg/mL) K151688chromID MRSA

View all 66 devices →

Related Devices (Code: LON)

K161227VITEK 2 AST-GN Cefepime (<=0.12->=32 ug/mL)bioMerieux, Inc. K152075VITEK 2 AST-Gram Negative Ertapenem (<=0.12 - >=8 ug/mL)bioMerieux, Inc. K151320BD Phoenix Automated Microbiology System-Ertapenem 0.0625-8 mcg/mlBecton, Dickinson and Company K172944VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 >=16 µg/mLbioMerieux, Inc. K172731VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL)bioMerieux, Inc. K162737VITEK 2 AST-GN Ciprofloxacin (<=0.06->=4µg/mL)bioMerieux, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.